Related Experiment Video
Updated: May 29, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Drug shortage: determinants, consequences and management].
Adriano Max Moreira Reis1, Edson Perini
1Agéncia Nacional de Vigiláncia Sanitária, Núcleo de Gestão do Sistema Sacional de Notificação e lnvestigação em Vigilância Sanitária, Geréncia de Farmacovigilância, SEPN 515, Bloco B, Edifício Omega, 2 andar/sala 2, Asa Norte. 70770-502 Brasilia DF. amreis@farmacia.ufmg.br
Ciencia & Saude Coletiva
|September 23, 2011
Summary
Drug shortages impact healthcare quality, safety, and cost, extending beyond logistics. Reclassifying drugs as health products, not consumer goods, is crucial for supply chain management.
Area of Science:
- Pharmacoeconomics
- Health Services Research
- Supply Chain Management
Context:
- Drug shortages present multifaceted challenges in healthcare delivery.
- The issue extends beyond mere logistics, affecting patient care quality and safety.
- Understanding the pharmaceutical supply chain is critical for drug availability.
Purpose:
- To analyze the broader implications of drug shortages.
- To discuss factors influencing drug distribution and availability.
- To propose strategies for managing drug shortages within health institutions.
Summary:
- This study examines drug shortages, highlighting their impact on healthcare quality, safety, and cost.
- It explores the pharmaceutical supply chain and factors affecting drug availability.
- The role of Pharmacy and Therapeutics Committees and suggested management measures are discussed.
Impact:
- Recommends treating pharmaceuticals as health products, not consumer goods, for improved supply chain handling.
- Provides insights for health institutions to prevent and manage drug shortages effectively.
- Emphasizes the need for a paradigm shift in pharmaceutical supply chain management.
Related Concept Videos
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:19Factors Affecting Drug Distribution: Miscellaneous Factors
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...